Global Clinical Reach RadMD’s extensive network supporting sites in over 80 countries presents significant opportunities to engage multinational pharmaceutical and biotech companies seeking reliable, worldwide imaging solutions for diverse clinical trial needs.

Specialized Oncology Services With a focus on oncology and a broad therapeutic portfolio, RadMD is well-positioned to attract sponsors with oncology drug candidates, especially those requiring advanced imaging or a comprehensive imaging strategy integrated within their trial workflows.

European Expansion RadMD’s recent European office expansion indicates a strategic move to serve EU-based clients, providing a foothold to target regional pharmaceutical firms and biotech companies seeking high-quality imaging and regulatory consulting locally.

Growth Potential As a mid-sized company with revenue between 25 to 50 million dollars and a growing global footprint, RadMD offers a compelling opportunity for partners looking to collaborate with an agile organization capable of scaling imaging services for larger clinical programs.

Partner Collaboration RadMD’s partnerships, such as with ICPME, and their comprehensive service offerings including regulatory and training support, open avenues for joint ventures or technology integrations to enhance existing clinical trial ecosystems.